XML 37 R25.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Earnings per Common Share (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2024
Earnings Per Share [Abstract] |
Schedule of Computation of Basic and Diluted Earnings Per Common Share | The following table sets forth the computation of basic and diluted earnings per common share (in millions, except per share amounts):
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2024 |  | 2023 |  | 2024 |  | 2023
Basic: |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |
Income from continuing operations | $ | 147.7 |  |  | $ | 118.4 |  |  | $ | 287.8 |  |  | $ | 232.7 |
Less: Net income attributable to noncontrolling interests included in continuing operations | (32.4) |  |  | (25.8) |  |  | (58.7) |  |  | (51.4) |
Less: Income allocated to participating securities | (0.8) |  |  | (0.6) |  |  | (1.6) |  |  | (1.2) |
Income from continuing operations attributable to Encompass Health common shareholders | 114.5 |  |  | 92.0 |  |  | 227.5 |  |  | 180.1 |
Loss from discontinued operations attributable to Encompass Health common shareholders | (1.2) |  |  | (1.2) |  |  | (2.5) |  |  | (2.2) |
Net income attributable to Encompass Health common shareholders | $ | 113.3 |  |  | $ | 90.8 |  |  | $ | 225.0 |  |  | $ | 177.9 |
Denominator: |  |  |  |  |  |  |
Basic weighted average common shares outstanding | 99.9 |  |  | 99.5 |  |  | 99.9 |  |  | 99.5 |
Basic earnings per share attributable to Encompass Health common shareholders: |  |  |  |  |  |  |
Continuing operations | $ | 1.14 |  |  | $ | 0.92 |  |  | $ | 2.28 |  |  | $ | 1.81 |
Discontinued operations | (0.01) |  |  | (0.01) |  |  | (0.03) |  |  | (0.02) |
Net income | $ | 1.13 |  |  | $ | 0.91 |  |  | $ | 2.25 |  |  | $ | 1.79 |
Diluted: |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |
Income from continuing operations | $ | 147.7 |  |  | $ | 118.4 |  |  | $ | 287.8 |  |  | $ | 232.7 |
Less: Net income attributable to noncontrolling interests included in continuing operations | (32.4) |  |  | (25.8) |  |  | (58.7) |  |  | (51.4) |
Income from continuing operations attributable to Encompass Health common shareholders | 115.3 |  |  | 92.6 |  |  | 229.1 |  |  | 181.3 |
Loss from discontinued operations attributable to Encompass Health common shareholders | (1.2) |  |  | (1.2) |  |  | (2.5) |  |  | (2.2) |
Net income attributable to Encompass Health common shareholders | $ | 114.1 |  |  | $ | 91.4 |  |  | $ | 226.6 |  |  | $ | 179.1 |
Denominator: |  |  |  |  |  |  |
Diluted weighted average common shares outstanding | 102.0 |  |  | 101.1 |  |  | 102.1 |  |  | 101.0 |
Diluted earnings per share attributable to Encompass Health common shareholders: |  |  |  |  |  |  |
Continuing operations | $ | 1.13 |  |  | $ | 0.91 |  |  | $ | 2.24 |  |  | $ | 1.79 |
Discontinued operations | (0.01) |  |  | (0.01) |  |  | (0.02) |  |  | (0.02) |
Net income | $ | 1.12 |  |  | $ | 0.90 |  |  | $ | 2.22 |  |  | $ | 1.77 |
Schedule of Reconciliation of Weighted Average Number of Shares Outstanding | The following table sets forth the reconciliation between basic weighted average common shares outstanding and diluted weighted average common shares outstanding (in millions):
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2024 |  | 2023 |  | 2024 |  | 2023
Basic weighted average common shares outstanding | 99.9 |  |  | 99.5 |  |  | 99.9 |  |  | 99.5 |
Restricted stock awards, dilutive stock options, and restricted stock units | 2.1 |  |  | 1.6 |  |  | 2.2 |  |  | 1.5 |
Diluted weighted average common shares outstanding | 102.0 |  |  | 101.1 |  |  | 102.1 |  |  | 101.0 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration